Clinical Trials Browser

Solid Tumor, Adult × Immune Checkpoint Inhibitors × Clear all

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT06026254 2024-11-18

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult